Initial report on intravesical administration of n-trifluoroacetyladriamycin-14-valerate (AD 32) to patients with refractory superficial transitional cell carcinoma of the urinary bladder

Author: Greenberg R.E.   Bahnson R.R.   Wood D.   Childs S.J.   Bellingham C.   Edson M.   Bamberger M.H.   Steinberg G.D.   Israel M.   Sweatman T.   Giantonio B.   O'Dwyer P.J.  

Publisher: Elsevier

ISSN: 0090-4295

Source: Urology, Vol.49, Iss.3, 1997-05, pp. : 471-475

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content